Lupin receives USFDA nod for Lorazepam Oral Concentrate
Quotes

Lupin receives USFDA nod for Lorazepam Oral Concentrate

Last Updated: Thursday, February 21, 2013, 17:45
 
 Comment 0
 
Lupin receives USFDA nod for Lorazepam Oral Concentrate
New Delhi: Drug firm Lupin Thursday said it has received US health regulator's approval to market its generic Lorazepam Oral Concentrate, used for treating anxiety disorders, in the American market.

Lupin Pharmaceuticals Inc, a subsidiary of Lupin, has received final approval from US Food and Drug Administration (USFDA) for its Lorazepam Oral Concentrate USP, Lupin Ltd said in a statement.

The Mumbai-headquartered firm's product is a generic version of Roxane Inc's Lorazepam Intensol and is indicated for the management of anxiety disorders or for the short- term relief of the symptoms of anxiety or anxiety associated with depressive symptoms, it added.

According to IMS MAT September 2012 sales data, Lorazepam Oral Concentrate had annual US sales of nearly USD 10.7 million.

Lupin scrip closed at Rs 594 on the BSE, down 0.21 percent from its previous close.

PTI



First Published: Thursday, February 21, 2013, 17:45


Comments


comments powered by Disqus
G20 Summit 2014
G20 Summit 2014
2014`s Top People in Business: Fortune
2014`s Top People in Business: Fortune
World Bank`s Top 10 Places for Business
World Bank`s Top 10 Places for Business
India`s top ten billionaires
India`s top ten billionaires
Top 10 billionaire cities- In Pics
Top 10 billionaire cities- In Pics

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved